Feasibility of intervention and procedures
nausea, dizziness, neck stiffness, headache, 3
ADVERSE EFFECTS
Of the 20 patients who participated in the trial, 100% completed baseline (TOut of 20 enrolled patients in the trial, a total of 7 patients (35%) reported mild (grade 1) adverse effects related to use of the VR device, all of which self-resolved following discontinuation of device use during that session. The remaining 13 patients experienced no AEs related to VR device use. The most frequently reported AE was dizziness (3 patients), followed by headache (2 patients), nausea (1 patient), and neck stiffness (1 patient). The 3 patients who reported headache and nausea had just begun chemotherapy treatment. Additionally, the 1 patient who reported neck stiffness was using the VR headset in “gaze mode” while lying down in bed, which likely caused this symptom and resolved when using the remote control for the headset.